Limits...
The effectiveness and cost-effectiveness of the Family Nurse Partnership home visiting programme for first time teenage mothers in England: a protocol for the Building Blocks randomised controlled trial.

Owen-Jones E, Bekkers MJ, Butler CC, Cannings-John R, Channon S, Hood K, Gregory JW, Kemp A, Kenkre J, Martin BC, Montgomery A, Moody G, Pickett KE, Richardson G, Roberts Z, Ronaldson S, Sanders J, Stamuli E, Torgerson D, Robling M - BMC Pediatr (2013)

Bottom Line: The Nurse Family Partnership programme was developed in the USA where it is made available to pregnant young mothers in some socially deprived geographic areas.The related Family Nurse Partnership programme was introduced in England by the Department of Health in 2006 with the aim of improving outcomes for the health, wellbeing and social circumstances of young first-time mothers and their children.Routine clinical data will be collected from maternity, primary care and hospital episodes statistics.

View Article: PubMed Central - HTML - PubMed

ABSTRACT

Background: The Nurse Family Partnership programme was developed in the USA where it is made available to pregnant young mothers in some socially deprived geographic areas. The related Family Nurse Partnership programme was introduced in England by the Department of Health in 2006 with the aim of improving outcomes for the health, wellbeing and social circumstances of young first-time mothers and their children.

Methods / design: This multi-centre individually randomised controlled trial will recruit 1600 participants from 18 Primary Care Trusts in England, United Kingdom. The trial will evaluate the effectiveness of Family Nurse Partnership programme and usual care versus usual care for iparous pregnant women aged 19 or under, recruited by 24 weeks gestation and followed until the child's second birthday. Data will be collected from participants at baseline, 34-36 weeks gestation, 6, 12, 18 and 24 months following birth. Routine clinical data will be collected from maternity, primary care and hospital episodes statistics. Four primary outcomes are to be reported from the trial: birth weight; prenatal tobacco use; child emergency attendances and/or admissions within two years of birth; second pregnancy within two years of first birth.

Discussion: This trial will evaluate the effectiveness and cost effectiveness of the Family Nurse Partnership in England. The findings will provide evidence on pregnancy and early childhood programme outcomes for policy makers, health professionals and potential recipients in three domains (pregnancy and birth, child health and development, and parental life course and self-sufficiency) up to the child's second birthday.

Trial registration: Trial registration number: ISRCTN23019866.

Show MeSH
Participant flow diagram and data collection.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC3750355&req=5

Figure 1: Participant flow diagram and data collection.

Mentions: A urine sample for cotinine assessment will be collected at the baseline visit and also at 34-36 weeks gestation. Following birth, medical and obstetric history items, antenatal attendances, and maternal and neonatal birth outcomes will be extracted from medical records onto a Case Report Form. Data relating to the number, duration and content of Family Nurse visits to participants will be captured on a Department of Health database which the trial team will access. The timing and methods of data collection are summarised in Figure 1.


The effectiveness and cost-effectiveness of the Family Nurse Partnership home visiting programme for first time teenage mothers in England: a protocol for the Building Blocks randomised controlled trial.

Owen-Jones E, Bekkers MJ, Butler CC, Cannings-John R, Channon S, Hood K, Gregory JW, Kemp A, Kenkre J, Martin BC, Montgomery A, Moody G, Pickett KE, Richardson G, Roberts Z, Ronaldson S, Sanders J, Stamuli E, Torgerson D, Robling M - BMC Pediatr (2013)

Participant flow diagram and data collection.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC3750355&req=5

Figure 1: Participant flow diagram and data collection.
Mentions: A urine sample for cotinine assessment will be collected at the baseline visit and also at 34-36 weeks gestation. Following birth, medical and obstetric history items, antenatal attendances, and maternal and neonatal birth outcomes will be extracted from medical records onto a Case Report Form. Data relating to the number, duration and content of Family Nurse visits to participants will be captured on a Department of Health database which the trial team will access. The timing and methods of data collection are summarised in Figure 1.

Bottom Line: The Nurse Family Partnership programme was developed in the USA where it is made available to pregnant young mothers in some socially deprived geographic areas.The related Family Nurse Partnership programme was introduced in England by the Department of Health in 2006 with the aim of improving outcomes for the health, wellbeing and social circumstances of young first-time mothers and their children.Routine clinical data will be collected from maternity, primary care and hospital episodes statistics.

View Article: PubMed Central - HTML - PubMed

ABSTRACT

Background: The Nurse Family Partnership programme was developed in the USA where it is made available to pregnant young mothers in some socially deprived geographic areas. The related Family Nurse Partnership programme was introduced in England by the Department of Health in 2006 with the aim of improving outcomes for the health, wellbeing and social circumstances of young first-time mothers and their children.

Methods / design: This multi-centre individually randomised controlled trial will recruit 1600 participants from 18 Primary Care Trusts in England, United Kingdom. The trial will evaluate the effectiveness of Family Nurse Partnership programme and usual care versus usual care for iparous pregnant women aged 19 or under, recruited by 24 weeks gestation and followed until the child's second birthday. Data will be collected from participants at baseline, 34-36 weeks gestation, 6, 12, 18 and 24 months following birth. Routine clinical data will be collected from maternity, primary care and hospital episodes statistics. Four primary outcomes are to be reported from the trial: birth weight; prenatal tobacco use; child emergency attendances and/or admissions within two years of birth; second pregnancy within two years of first birth.

Discussion: This trial will evaluate the effectiveness and cost effectiveness of the Family Nurse Partnership in England. The findings will provide evidence on pregnancy and early childhood programme outcomes for policy makers, health professionals and potential recipients in three domains (pregnancy and birth, child health and development, and parental life course and self-sufficiency) up to the child's second birthday.

Trial registration: Trial registration number: ISRCTN23019866.

Show MeSH